@inproceedings{inproceedings, title  = {{Autologous stem cell transplantation versus alemtuzumab or ocrelizumab in relapsing remitting multiple sclerosis (starms)}},

 url = {{}},

 year = {{2020}},

 month = {{1}},

 author = {{Sharrack B and Snowden J and Muraro P}},

 volume = {{26}},

 journal = {{MULTIPLE SCLEROSIS JOURNAL}},

 issue = {{3_SUPPL}},

 pages = {{209-210}},

 note = {{Accessed on 2024/12/22}}}